fluoxetine has been researched along with Cataleptic Attacks in 7 studies
Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The majority of recent papers in this field provide information about use of modafinil or sodium oxybate for treatment of sleepiness associated with narcolepsy." | 4.84 | Treatment of narcolepsy and other hypersomnias of central origin. ( Arand, DL; Auger, RR; Brooks, SN; Watson, NF; Wise, MS, 2007) |
| "Successful treatment of hypersomnia of central origin requires an accurate diagnosis, individual tailoring of therapy to produce the fullest possible return of normal function, and regular follow-up to monitor response to treatment." | 2.44 | Practice parameters for the treatment of narcolepsy and other hypersomnias of central origin. ( Alessi, C; Aurora, RN; Boehlecke, B; Brown, T; Chesson, AL; Friedman, L; Kapur, VK; Maganti, R; Morgenthaler, TI; Owens, J; Pancer, J; Swick, TJ; Zak, R, 2007) |
| "Thus, experimental cataplexy is suppressed more by inhibition of the uptake of NE than of 5-HT." | 1.26 | Monoaminergic mechanisms and experimental cataplexy. ( Delashaw, JB; Dement, WC; Foutz, AS; Guilleminault, C, 1981) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Soltanifar, S | 1 |
| Russell, R | 1 |
| Poryazova, R | 1 |
| Siccoli, M | 1 |
| Werth, E | 1 |
| Bassetti, CL | 1 |
| Morgenthaler, TI | 1 |
| Kapur, VK | 1 |
| Brown, T | 1 |
| Swick, TJ | 1 |
| Alessi, C | 1 |
| Aurora, RN | 1 |
| Boehlecke, B | 1 |
| Chesson, AL | 1 |
| Friedman, L | 1 |
| Maganti, R | 1 |
| Owens, J | 1 |
| Pancer, J | 1 |
| Zak, R | 1 |
| Wise, MS | 1 |
| Arand, DL | 1 |
| Auger, RR | 1 |
| Brooks, SN | 1 |
| Watson, NF | 1 |
| Foutz, AS | 1 |
| Delashaw, JB | 1 |
| Guilleminault, C | 1 |
| Dement, WC | 1 |
| Frey, J | 1 |
| Darbonne, C | 1 |
| Langdon, N | 1 |
| Shindler, J | 1 |
| Parkes, JD | 1 |
| Bandak, S | 1 |
2 reviews available for fluoxetine and Cataleptic Attacks
| Article | Year |
|---|---|
Practice parameters for the treatment of narcolepsy and other hypersomnias of central origin.
Topics: Antidepressive Agents, Tricyclic; Benzhydryl Compounds; Cataplexy; Central Nervous System Stimulants | 2007 |
Treatment of narcolepsy and other hypersomnias of central origin.
Topics: Antidepressive Agents, Tricyclic; Benzhydryl Compounds; Cataplexy; Central Nervous System Stimulants | 2007 |
5 other studies available for fluoxetine and Cataleptic Attacks
| Article | Year |
|---|---|
Neuraxial anaesthesia for caesarean section in a patient with narcolepsy and cataplexy.
Topics: Adult; Anesthesia, Epidural; Anesthesia, Obstetrical; Antidepressive Agents, Second-Generation; Benz | 2010 |
Unusually prolonged rebound cataplexy after withdrawal of fluoxetine.
Topics: Brain Stem; Cataplexy; Electroencephalography; Electromyography; Female; Fluoxetine; Humans; Middle | 2005 |
Monoaminergic mechanisms and experimental cataplexy.
Topics: Animals; Antidepressive Agents, Tricyclic; Biogenic Amines; Cataplexy; Dogs; Female; Fluoxetine; Hal | 1981 |
Fluoxetine suppresses human cataplexy: a pilot study.
Topics: Aged; Cataplexy; Dose-Response Relationship, Drug; Female; Fluoxetine; Follow-Up Studies; Humans; Ma | 1994 |
Fluoxetine in the treatment of cataplexy.
Topics: Cataplexy; Female; Fluoxetine; Humans; Male | 1986 |